EVENTS
July 1 2010 InsuLine have submitted a Prospectus to the Israel Securities Authority towards Initial public offering in the Tel Aviv stock exchange market . You can view the
Prospectus here along with the
Presentation for the Road show.
NEWS
During the last month several articles have been published about InsuLine, it’s technology and it’s business plans. Click on the links below to view the articles (Hebrew)
SCIENTIFIC PUBLICATIONS & CONFERENCES
Clinical results regarding the usage of the InsuPatch device were published in conferences and scientific Journal. Below are links to some of the publications made by InsuLine or by other researchers regarding the usage of the InsuPatch device.
A summary of the results of a clinical study conducted by Roche at Ulm University was accepted to the Planned EASD meeting to be held at Stockholm on September 2010.The title of the study is:
Clinical performance of the insulin infusion set InsuPatch that applies local heat to the infusion site G. Freckmann1, A. Westhoff(1), S. Pleus1, N. Jendrike(1), E. Zschornack(1), C. Haug(1), L. Krinelke(2); (1) Institute for Diabetes-Technology GmbH at the University of Ulm, Ulm, Germany,( 2) Roche Diabetes Care AG, Burgdorf, Switzerland.
A summary of a clinical study conducted by InsuLine was published in the
May Issue of Clinical Therapeutics on 2009.
Invited Oral presentation of Insuline was given at the ATTD 2010, Basel Switzerland. The title of the talk was , “
Disposable devices to accelerate insulin delivery”.
Back to top
